Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.41B |
| 2 |
American Tower
AMT
|
+$272M |
| 3 |
Microsoft
MSFT
|
+$271M |
| 4 |
Zoom
ZM
|
+$245M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TIF
Tiffany & Co.
TIF
|
+$206M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
+$200M |
| 3 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$186M |
| 4 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$151M |
| 5 |
Pfizer
PFE
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.25% |
| 2 | Healthcare | 13.6% |
| 3 | Financials | 13.05% |
| 4 | Consumer Discretionary | 12.39% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGRX
2376
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $7.31M | ﹤0.01% |
156,949
-2,932
| -2% | -$137K |
|
|
ALTA
2377
DELISTED
Altabancorp
ALTA
| $7.31M | ﹤0.01% |
261,728
-2,463
| -0.9% | -$62.5K |
|
2378
First Mid Bancshares
FMBH
$1.39B
| $7.3M | ﹤0.01% |
217,003
+5,933
| +3% | +$179K |
|
2379
Transmedics
TMDX
$2.64B
| $7.28M | ﹤0.01% |
366,049
+34,721
| +10% | +$514K |
|
2380
HUTCHMED
HCM
$2.01B
| $7.27M | ﹤0.01% |
228,952
+7,349
| +3% | +$226K |
|
2381
Geron
GERN
$1.05B
| $7.25M | ﹤0.01% |
4,558,494
+11,125
| +0.2% | +$20.3K |
|
|
DCOM
2382
DELISTED
Dime Community Bancshares
DCOM
| $7.24M | ﹤0.01% |
459,379
+6,628
| +1% | +$92.6K |
|
|
BFS
2383
Saul Centers
BFS
$825M
| $7.24M | ﹤0.01% |
228,660
+45,853
| +25% | +$1.35M |
|
2384
World Acceptance Corp
WRLD
$897M
| $7.24M | ﹤0.01% |
70,826
-378
| -0.5% | -$40K |
|
2385
MasterCraft Boat Holdings
MCFT
$610M
| $7.23M | ﹤0.01% |
291,193
+7,504
| +3% | +$167K |
|
|
ZIXI
2386
DELISTED
Zix Corporation
ZIXI
| $7.23M | ﹤0.01% |
837,854
+16,040
| +2% | +$114K |
|
2387
JFrog
FROG
$10.2B
| $7.21M | ﹤0.01% |
114,776
+52,423
| +84% | +$3.65M |
|
2388
OptimizeRx
OPRX
$130M
| $7.19M | ﹤0.01% |
230,660
+30,933
| +15% | +$758K |
|
|
SPNS
2389
DELISTED
Sapiens International
SPNS
| $7.17M | ﹤0.01% |
234,347
+24,251
| +12% | +$711K |
|
2390
Dillards
DDS
$9.63B
| $7.17M | ﹤0.01% |
113,714
-6,919
| -6% | -$338K |
|
2391
Ascendis Pharma A/S
ASND
$16B
| $7.15M | ﹤0.01% |
42,864
+3,668
| +9% | +$607K |
|
|
DEN
2392
DELISTED
Denbury Inc.
DEN
| $7.15M | ﹤0.01% |
+278,173
| New | +$5.65M |
|
|
JOBS
2393
DELISTED
51job Inc
JOBS
| $7.14M | ﹤0.01% |
102,690
+3,652
| +4% | +$264K |
|
2394
Ennis
EBF
$562M
| $7.12M | ﹤0.01% |
398,798
+12,150
| +3% | +$205K |
|
|
STEL
2395
DELISTED
Stellar Bancorp
STEL
| $7.12M | ﹤0.01% |
279,031
+3,467
| +1% | +$74.8K |
|
|
DHIL
2396
DELISTED
Diamond Hill
DHIL
| $7.09M | ﹤0.01% |
47,533
-3,784
| -7% | -$551K |
|
|
AMTI
2397
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $7.09M | ﹤0.01% |
230,509
-2,208
| -0.9% | -$70K |
|
|
PAYA
2398
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $7.08M | ﹤0.01% |
+521,254
| New | +$6.06M |
|
|
TECX
2399
Tectonic Therapeutic
TECX
$558M
| $7.07M | ﹤0.01% |
42,242
+6,686
| +19% | +$1.19M |
|
|
VXRT
2400
DELISTED
Vaxart
VXRT
| $7.05M | ﹤0.01% |
1,235,724
+68,181
| +6% | +$434K |
|
Similar funds
Geode Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Geode Capital Management held 4,369 positions worth $596B, up 17% from $510B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q4 2020 filing shows 215 new, 3,067 increased, 650 reduced and 100 closed positions. Its largest new stake was Apartment Income REIT Corp.: 2,223,585 shares worth $85.4M. The largest sale was Tiffany & Co., an estimated $206M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q4 2020 buy was Apartment Income REIT Corp.: 2,223,585 shares worth $85.4M.
- Geode Capital Management added most to Tesla in Q4 2020, an estimated $2.41B increase.
- Geode Capital Management's biggest Q4 2020 reduction was Pfizer, cutting an estimated $131M.
- Geode Capital Management fully exited Tiffany & Co. in Q4 2020, selling an estimated $206M.
- Geode Capital Management's ten largest holdings make up 22% of its $596B portfolio in Q4 2020.
- Geode Capital Management opened 215 new positions and closed 100 in Q4 2020.
- Geode Capital Management's portfolio value rose 17% quarter-over-quarter to $596B.
Based on Geode Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.